Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3892 Target Snapshot

Sphingosine 1-phosphate receptor 3 · SINGLE PROTEIN · Homo sapiens

2,947Compounds
224Assays
4Approved Drugs
3,664.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q99500. Use UniProt Q99500 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q99500 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sphingosine 1-phosphate receptor 3 as ChEMBL target CHEMBL3892, mapped to UniProt Q99500. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sphingosine 1-phosphate receptor 3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL3892
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q99500
Sphingosine 1-phosphate receptor 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sphingosine 1-phosphate receptor 3 is the right protein anchor across sources, using UniProt Q99500 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSphingosine 1-phosphate receptor 3
UniProt AccessionQ99500
Component TypeProtein
Sequence Length378 aa

Sphingosine 1-phosphate receptor 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sphingosine 1-phosphate receptor 3, mapped to UniProt Q99500. Sequence length is 378 aa.

Mapped IDQ99500
Review nameSphingosine 1-phosphate receptor 3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

4
Approved
1
Phase I
Assay Mix

Activity Type Distribution

IC501,297.0
KI7.0
EC502,352.0
KD8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL225155 10.4 IC50 0.04 Preclinical
CHEMBL114606 10.0 EC50 0.1 Preclinical
CHEMBL366208 9.87 EC50 0.134 Preclinical
CHEMBL1089004 9.82 EC50 0.15 Preclinical
CHEMBL199791 9.75 EC50 0.1778 Preclinical
CHEMBL225155 9.7 EC50 0.2 Preclinical
CHEMBL1091103 9.67 EC50 0.215 Preclinical
CHEMBL1093686 9.54 EC50 0.286 Preclinical
CHEMBL473156 9.44 IC50 0.36 Preclinical
CHEMBL432067 9.15 IC50 0.71 Preclinical
Distribution

pChEMBL Value Distribution

278
5.0
418
5.5
410
6.0
321
6.5
247
7.0
167
7.5
81
8.0
36
8.5
12
9.0
7
9.5
pChEMBL
Approved Drugs

Approved Drugs

PONESIMOD
CHEMBL1096146
Approved 2021
FINGOLIMOD
CHEMBL314854
Approved 2010
Assay Landscape

Assay Landscape

224
Total Assays
896
Tested Compounds
3
Assay Types
Functional — 122 assays, 709 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 92 593 6.2
assay format 24 93 6.6
cell membrane format 3 21 5.4
single protein format 3 2 7.4
Binding — 94 assays, 896 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 49 212 6.6
single protein format 34 638 6.6
assay format 6 19 6.2
cell membrane format 5 27 5.3
ADME — 8 assays, 32 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 5 7 5.9
assay format 2 24 5.3
cell membrane format 1 1 8.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine